Company: BLCO
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013244
Chunk: 15

Company: Bausch & Lomb Corp
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 15
---
, M.D. |     |        8 |     | 100 |     |         — |     |   — |     |                  4 |     | 100 |     |           4 |     | 100 |     |            — |     |   — |     | 16/16   |     | 100 |

| (1) | Mr. De Schutter resigned from the Board and its committees effective March 29, 2024 and his attendance is based on meetings held up to that date. |

| (2) | Mr. Icahn resigned from the Nominating and Corporate Governance Committee effective May 29, 2024 and his attendance is based on meetings held up to that date. |

| (3) | Ms. Ling joined the Board on February 27, 2024 and the Talent and Compensation Committee on May 29, 2024 and her attendance is based on meetings held as of her appointment. |

Executive Session The Corporate Governance Guidelines provide that the independent directors of the Board may meet in executive session at any meeting of the Board, and that an opportunity shall be provided during the meeting for any member of the Board to make such a request. The independent directors generally meet in executive sessions without management present during their regularly scheduled Board and committee meetings, and on an as-needed basis during ad hoc meetings. Mr. Ross, our Lead Independent Director, presides over executive sessions of the Board, and the committee chairs, all of whom are independent, preside over executive sessions of the Committees. During 2024, our independent directors held executive sessions at each of the four regularly scheduled Board meetings. Annual Meeting of Shareholders Although we do not have a formal policy requiring our directors to attend our annual meetings of shareholders, we encourage all directors to attend our annual meetings. Annual Evaluation Process The Nominating and Corporate Governance Committee annually develops and recommends processes for assessing the performance and effectiveness of the Board and the committees of the Board and reports the results of such assessments to the Board on an annual basis. In 2024, the Nominating and Corporate Governance Committee recommended to the Board that the Board and committees each complete self-assessments, including a review of the compliance of the Board and each committee with their respective charters, the adequacy of information provided, the skills and experience of the members, and other matters. After a review of the results by the Chairman of the Board and Lead Independent Director, the results were shared with the Board and each standing committee for